<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.2"?>
<!-- generated-on="2026-07-18T21:03:54+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.2" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.pharmaglobenewswire.com/shingles-pipeline-insight-2026-comprehensive-analysis-of-emerging-therapies-and-clinical-development/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-17T11:53:58+01:00</news:publication_date><news:title>Shingles Pipeline Insight 2026: Comprehensive Analysis of Emerging Therapies and Clinical Development</news:title></news:news></url>
<url><loc>https://www.pharmaglobenewswire.com/minimal-residual-disease-market-set-to-witness-significant-growth-driven-by-rising-cancer-incidence-technological-advancements-and-expanding-testing-adoption-through-2032/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-17T10:48:04+01:00</news:publication_date><news:title>Minimal Residual Disease Market Set to Witness Significant Growth Driven by Rising Cancer Incidence, Technological Advancements, and Expanding Testing Adoption Through 2032</news:title></news:news></url>
</urlset>
